Elena Peeva, M.D., M.Sc., Gisele Zandman-Goddard, M.D., and Peter Barland, M.D.
Dr. Peeva is Instructor of Medicine at the Albert Einstein College of Medicine and Attending Physician at Montefiore Medical Center, New York; Dr. Zandman-Goddard is Instructor of Medicine and Attending Physician at Sheba Medical Center, Israel.Drs. Peeva, Zandman-Goddard and Barland report no commercial conflicts of interest.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Describe the mechanism of action and major side effects of the new cytotoxic agents used in treatment of SLE: MMF, fludarabine and cladribine
Discuss induction of B cell tolerance by LJP 394
Describe the stem cell restoration treatment and the mechanism of action and effects of intravenous immunoglobulin
Describe the mechanism of action of targeted molecular therapies.
